Rafferty Asset Management
XERS icon

Rafferty Asset Management’s Xeris Biopharma Holdings XERS Stock Holding History

Rafferty Asset Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$141K Sell
24,247
-9,442
-28% -$62.6K ﹤0.01% 1041
2025
Q4 		$264K Buy
33,689
+16,278
+93% +$128K ﹤0.01% 1022
2025
Q3 		$142K Sell
17,411
-8,492
-33% -$56.4K ﹤0.01% 1090
2025
Q2 		$121K Buy
25,903
+10,900
+73% +$49.9K ﹤0.01% 1066
2025
Q1 		$82.4K Sell
15,003
-2,717
-15% -$11K ﹤0.01% 1049
2024
Q4 		$60.1K Sell
17,720
-1,392
-7% -$4.48K ﹤0.01% 1137
2024
Q3 		$54.5K Sell
19,112
-424
-2% -$1.09K ﹤0.01% 1136
2024
Q2 		$44K Sell
19,536
-1,677
-8% -$3.38K ﹤0.01% 1168
2024
Q1 		$46.9K Buy
+21,213
New +$54.9K ﹤0.01% 1078
2022
Q3 		– Sell
-35,248
Closed -$54K – 1260
2022
Q2 		$54K Buy
35,248
+4,105
+13% +$8.66K ﹤0.01% 1098
2022
Q1 		$80K Sell
31,143
-12,198
-28% -$29.8K ﹤0.01% 1189
2021
Q4 		$127K Buy
43,341
+14,174
+49% +$30.6K ﹤0.01% 1246
2021
Q3 		$71K Buy
+29,167
New +$84.7K ﹤0.01% 1248

Other funds holding XERS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $244M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return